{"transactions":[{"id":4035373,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Restricted Stock Units","published_at":"2018-02-26T19:30:23.000Z","date":"2018-02-25","kind":"exercise","acquired":false,"shares":930,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On February 25, 2016, the reporting person was granted 1,860 restricted stock units, vesting in two equal annual installments beginning on the second anniversary of the grant date."}],"balance_after":930,"derivative":{"expiration_date":"2026-02-25","underlying":"Common Stock","underlying_shares":930},"source":{"system":"sec-edgar","filing":"0001209191-18-013642","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919118013642/doc4.xml","form_type":"4"}},{"id":4035372,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Stock Appreciation Right","published_at":"2018-02-26T19:30:23.000Z","date":"2018-02-22","kind":"grant","acquired":true,"shares":1050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"On February 5, 2014, the reporting person was granted 7,000 stock appreciation rights. The stock appreciation rights were eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2017, 60% of the stock appreciation rights subject to such criteria vested, resulting in the vesting of 1,050 stock appreciation rights."}],"balance_after":1050,"derivative":{"exercise_price":47.97,"exercise_date":"2018-02-22","expiration_date":"2024-02-05","underlying":"Common Stock","underlying_shares":1050},"source":{"system":"sec-edgar","filing":"0001209191-18-013642","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919118013642/doc4.xml","form_type":"4"}},{"id":4035371,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Common Stock","published_at":"2018-02-26T19:30:23.000Z","date":"2018-02-25","kind":"tax_withholding","acquired":false,"shares":227,"price":100.84,"value":22890.68,"ownership":{"direct":true},"balance_after":7003,"source":{"system":"sec-edgar","filing":"0001209191-18-013642","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919118013642/doc4.xml","form_type":"4"}},{"id":4035370,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Common Stock","published_at":"2018-02-26T19:30:23.000Z","date":"2018-02-25","kind":"exercise","acquired":true,"shares":930,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":7230,"source":{"system":"sec-edgar","filing":"0001209191-18-013642","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919118013642/doc4.xml","form_type":"4"}},{"id":4035369,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Common Stock","published_at":"2018-02-26T19:30:23.000Z","date":"2018-02-22","kind":"tax_withholding","acquired":false,"shares":3151,"price":100.54,"value":316801.54,"ownership":{"direct":true},"balance_after":6300,"source":{"system":"sec-edgar","filing":"0001209191-18-013642","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919118013642/doc4.xml","form_type":"4"}},{"id":4035368,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Common Stock","published_at":"2018-02-26T19:30:23.000Z","date":"2018-02-22","kind":"grant","acquired":true,"shares":300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On February 5, 2014, the reporting person was granted 2,000 restricted stock units. The restricted stock units were eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2017, 60% of the restricted stock units subject to such criteria vested, resulting in the vesting of 300 restricted stock units."}],"balance_after":9451,"source":{"system":"sec-edgar","filing":"0001209191-18-013642","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919118013642/doc4.xml","form_type":"4"}},{"id":4035367,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Common Stock","published_at":"2018-02-26T19:30:23.000Z","date":"2018-02-22","kind":"grant","acquired":true,"shares":8800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 4, 2015, the reporting person was granted 4,400 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2015-2017. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2015-2017 earnings per share, the number of performance share units that vested equaled two times the units granted."}],"balance_after":9151,"source":{"system":"sec-edgar","filing":"0001209191-18-013642","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919118013642/doc4.xml","form_type":"4"}},{"id":4072955,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Restricted Stock Units","published_at":"2018-02-07T20:23:52.000Z","date":"2018-02-05","kind":"exercise","acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":0,"derivative":{"exercise_date":"2018-02-05","expiration_date":"2024-02-05","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001209191-18-008287","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919118008287/doc4.xml","form_type":"4"}},{"id":4072954,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Common Stock","published_at":"2018-02-07T20:23:52.000Z","date":"2018-02-05","kind":"tax_withholding","acquired":false,"shares":149,"price":95.89,"value":14287.61,"ownership":{"direct":true},"balance_after":351,"source":{"system":"sec-edgar","filing":"0001209191-18-008287","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919118008287/doc4.xml","form_type":"4"}},{"id":4072953,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Common Stock","published_at":"2018-02-07T20:23:52.000Z","date":"2018-02-05","kind":"exercise","acquired":true,"shares":500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":500,"source":{"system":"sec-edgar","filing":"0001209191-18-008287","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919118008287/doc4.xml","form_type":"4"}},{"id":4080321,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Stock Appreciation Right","published_at":"2018-02-02T19:33:21.000Z","date":"2018-01-31","kind":"grant","acquired":true,"shares":18300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019."}],"balance_after":18300,"derivative":{"exercise_price":101.16,"exercise_date":"2019-01-31","expiration_date":"2028-01-31","underlying":"Common Stock","underlying_shares":18300},"source":{"system":"sec-edgar","filing":"0001209191-18-007219","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919118007219/doc4.xml","form_type":"4"}},{"id":4080320,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Stock Appreciation Right","published_at":"2018-02-02T19:33:21.000Z","date":"2018-01-31","kind":"exercise","acquired":false,"shares":5125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The stock appreciation rights vest in four equal annual installments beginning on January 29, 2017."}],"balance_after":5125,"derivative":{"exercise_price":69.58,"expiration_date":"2026-01-29","underlying":"Common Stock","underlying_shares":5125},"source":{"system":"sec-edgar","filing":"0001209191-18-007219","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919118007219/doc4.xml","form_type":"4"}},{"id":4080319,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Stock Appreciation Right","published_at":"2018-02-02T19:33:21.000Z","date":"2018-01-31","kind":"exercise","acquired":false,"shares":2750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The stock appreciation rights vest in four equal annual installments beginning on February 4, 2016."}],"balance_after":5500,"derivative":{"exercise_price":68.96,"expiration_date":"2025-02-04","underlying":"Common Stock","underlying_shares":2750},"source":{"system":"sec-edgar","filing":"0001209191-18-007219","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919118007219/doc4.xml","form_type":"4"}},{"id":4080318,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Stock Appreciation Right","published_at":"2018-02-02T19:33:21.000Z","date":"2018-01-31","kind":"exercise","acquired":false,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock appreciation rights vest in four equal annual installments beginning on February 5, 2015."}],"balance_after":1750,"derivative":{"exercise_price":47.97,"expiration_date":"2024-02-05","underlying":"Common Stock","underlying_shares":1750},"source":{"system":"sec-edgar","filing":"0001209191-18-007219","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919118007219/doc4.xml","form_type":"4"}},{"id":4080317,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Stock Appreciation Right","published_at":"2018-02-02T19:33:21.000Z","date":"2018-01-31","kind":"exercise","acquired":false,"shares":1400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock appreciation rights vested at the end of fiscal year 2016 based upon the achievement of certain annual EBITDA performance targets."}],"balance_after":0,"derivative":{"exercise_price":47.97,"expiration_date":"2024-02-05","underlying":"Common Stock","underlying_shares":1400},"source":{"system":"sec-edgar","filing":"0001209191-18-007219","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919118007219/doc4.xml","form_type":"4"}},{"id":4080316,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Stock Appreciation Right","published_at":"2018-02-02T19:33:21.000Z","date":"2018-01-31","kind":"exercise","acquired":false,"shares":1700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets."}],"balance_after":0,"derivative":{"exercise_price":37.18,"expiration_date":"2023-02-06","underlying":"Common Stock","underlying_shares":1700},"source":{"system":"sec-edgar","filing":"0001209191-18-007219","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919118007219/doc4.xml","form_type":"4"}},{"id":4080315,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Stock Appreciation Right","published_at":"2018-02-02T19:33:21.000Z","date":"2018-01-31","kind":"exercise","acquired":false,"shares":2125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock appreciation rights vested in four equal annual installments beginning on February 6, 2014."}],"balance_after":0,"derivative":{"exercise_price":37.18,"expiration_date":"2023-02-06","underlying":"Common Stock","underlying_shares":2125},"source":{"system":"sec-edgar","filing":"0001209191-18-007219","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919118007219/doc4.xml","form_type":"4"}},{"id":4080314,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Common Stock","published_at":"2018-02-02T19:33:21.000Z","date":"2018-02-02","kind":"sale","acquired":false,"shares":5702,"price":102.009,"value":581655.318,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.00 to $102.041, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-007219","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919118007219/doc4.xml","form_type":"4"}},{"id":4080313,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Common Stock","published_at":"2018-02-02T19:33:21.000Z","date":"2018-02-01","kind":"sale","acquired":false,"shares":10000,"price":101.5,"value":1015000.0,"ownership":{"direct":false,"nature":"By GRAT (Spouse, Trustee)"},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-007219","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919118007219/doc4.xml","form_type":"4"}},{"id":4080312,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Common Stock","published_at":"2018-02-02T19:33:21.000Z","date":"2018-02-01","kind":"sale","acquired":false,"shares":568.0531,"price":103.08,"value":58554.913548,"ownership":{"direct":true},"balance_after":5702,"source":{"system":"sec-edgar","filing":"0001209191-18-007219","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919118007219/doc4.xml","form_type":"4"}},{"id":4080311,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Common Stock","published_at":"2018-02-02T19:33:21.000Z","date":"2018-01-31","kind":"tax_withholding","acquired":false,"shares":9937,"price":101.16,"value":1005226.92,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 568.0531 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan."}],"balance_after":6270.0531,"source":{"system":"sec-edgar","filing":"0001209191-18-007219","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919118007219/doc4.xml","form_type":"4"}},{"id":4080310,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Common Stock","published_at":"2018-02-02T19:33:21.000Z","date":"2018-01-31","kind":"exercise","acquired":true,"shares":5125,"price":69.58,"value":356597.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 568.0531 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan."}],"balance_after":16207.0531,"source":{"system":"sec-edgar","filing":"0001209191-18-007219","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919118007219/doc4.xml","form_type":"4"}},{"id":4080309,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Common Stock","published_at":"2018-02-02T19:33:21.000Z","date":"2018-01-31","kind":"exercise","acquired":true,"shares":2750,"price":68.96,"value":189640.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 568.0531 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan."}],"balance_after":11082.0531,"source":{"system":"sec-edgar","filing":"0001209191-18-007219","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919118007219/doc4.xml","form_type":"4"}},{"id":4080308,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Common Stock","published_at":"2018-02-02T19:33:21.000Z","date":"2018-01-31","kind":"exercise","acquired":true,"shares":3150,"price":47.97,"value":151105.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 568.0531 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan."}],"balance_after":8332.0531,"source":{"system":"sec-edgar","filing":"0001209191-18-007219","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919118007219/doc4.xml","form_type":"4"}},{"id":4080307,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Common Stock","published_at":"2018-02-02T19:33:21.000Z","date":"2018-01-31","kind":"exercise","acquired":true,"shares":3825,"price":37.18,"value":142213.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 568.0531 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan."}],"balance_after":5182.0531,"source":{"system":"sec-edgar","filing":"0001209191-18-007219","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919118007219/doc4.xml","form_type":"4"}},{"id":4369834,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-03-29T21:13:27.000Z","date":"2017-03-27","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option vested at the end of fiscal year 2011 based upon the achievement of certain annual EBITDA performance targets."}],"balance_after":0,"derivative":{"exercise_price":22.1,"expiration_date":"2021-11-02","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-17-023543","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919117023543/doc4.xml","form_type":"4"}},{"id":4369833,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-03-29T21:13:27.000Z","date":"2017-03-27","kind":"exercise","acquired":false,"shares":3125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":0,"derivative":{"exercise_price":21.35,"exercise_date":"2012-11-02","expiration_date":"2021-11-02","underlying":"Common Stock","underlying_shares":3125},"source":{"system":"sec-edgar","filing":"0001209191-17-023543","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919117023543/doc4.xml","form_type":"4"}},{"id":4369832,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-03-29T21:13:27.000Z","date":"2017-03-27","kind":"exercise","acquired":false,"shares":9375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option vested in three equal installments at the end of fiscal years 2012, 2013 and 2014 based upon the achievement of certain annual EBITDA performance targets."}],"balance_after":0,"derivative":{"exercise_price":17.33,"expiration_date":"2021-11-02","underlying":"Common Stock","underlying_shares":9375},"source":{"system":"sec-edgar","filing":"0001209191-17-023543","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919117023543/doc4.xml","form_type":"4"}},{"id":4369831,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-03-29T21:13:27.000Z","date":"2017-03-27","kind":"exercise","acquired":false,"shares":9375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option vested in three equal annual installments beginning on November 2, 2013."}],"balance_after":0,"derivative":{"exercise_price":17.33,"expiration_date":"2021-11-02","underlying":"Common Stock","underlying_shares":9375},"source":{"system":"sec-edgar","filing":"0001209191-17-023543","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919117023543/doc4.xml","form_type":"4"}},{"id":4369830,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-03-29T21:13:27.000Z","date":"2017-03-27","kind":"exercise","acquired":false,"shares":1184,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vested at the end of fiscal year 2009 based upon the achievement of certain annual EBITDA performance targets."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011."}],"balance_after":0,"derivative":{"exercise_price":15.9112,"expiration_date":"2019-08-27","underlying":"Common Stock","underlying_shares":1184},"source":{"system":"sec-edgar","filing":"0001209191-17-023543","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919117023543/doc4.xml","form_type":"4"}},{"id":4369829,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-03-29T21:13:27.000Z","date":"2017-03-27","kind":"exercise","acquired":false,"shares":1892,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vested in equal increments (i) at the end of fiscal year 2012 upon the achievement of certain annual EBITDA performance targets and (ii) upon a change in control (as defined in the 2006 Stock Incentive Plan for Key Employees of HCA Holdings, Inc. and its Affiliates as Amended and Restated) of the Issuer which occurred effective November 1, 2013."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011."}],"balance_after":0,"derivative":{"exercise_price":5.9821,"expiration_date":"2019-08-27","underlying":"Common Stock","underlying_shares":1892},"source":{"system":"sec-edgar","filing":"0001209191-17-023543","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919117023543/doc4.xml","form_type":"4"}},{"id":4369828,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-03-29T21:13:27.000Z","date":"2017-03-27","kind":"exercise","acquired":false,"shares":4505,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was scheduled to vest in three equal annual installments beginning on August 27, 2012. A change in control of the Issuer occurred effective November 1, 2013, resulting in the accelerated vesting of the option as to the shares that remained unvested."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011."}],"balance_after":0,"derivative":{"exercise_price":5.9821,"expiration_date":"2019-08-27","underlying":"Common Stock","underlying_shares":4505},"source":{"system":"sec-edgar","filing":"0001209191-17-023543","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919117023543/doc4.xml","form_type":"4"}},{"id":4369827,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Common Stock","published_at":"2017-03-29T21:13:27.000Z","date":"2017-03-27","kind":"sale","acquired":false,"shares":31956,"price":90,"value":2876040.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":1357.0531,"source":{"system":"sec-edgar","filing":"0001209191-17-023543","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919117023543/doc4.xml","form_type":"4"}},{"id":4369826,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Common Stock","published_at":"2017-03-29T21:13:27.000Z","date":"2017-03-27","kind":"exercise","acquired":true,"shares":2500,"price":22.1,"value":55250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":33313.0531,"source":{"system":"sec-edgar","filing":"0001209191-17-023543","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919117023543/doc4.xml","form_type":"4"}},{"id":4369825,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Common Stock","published_at":"2017-03-29T21:13:27.000Z","date":"2017-03-27","kind":"exercise","acquired":true,"shares":3125,"price":21.35,"value":66718.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":30813.0531,"source":{"system":"sec-edgar","filing":"0001209191-17-023543","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919117023543/doc4.xml","form_type":"4"}},{"id":4369824,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Common Stock","published_at":"2017-03-29T21:13:27.000Z","date":"2017-03-27","kind":"exercise","acquired":true,"shares":18750,"price":17.33,"value":324937.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":27688.0531,"source":{"system":"sec-edgar","filing":"0001209191-17-023543","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919117023543/doc4.xml","form_type":"4"}},{"id":4369823,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Common Stock","published_at":"2017-03-29T21:13:27.000Z","date":"2017-03-27","kind":"exercise","acquired":true,"shares":1184,"price":15.9112,"value":18838.8608,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":8938.0531,"source":{"system":"sec-edgar","filing":"0001209191-17-023543","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919117023543/doc4.xml","form_type":"4"}},{"id":4369822,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Common Stock","published_at":"2017-03-29T21:13:27.000Z","date":"2017-03-27","kind":"exercise","acquired":true,"shares":6397,"price":5.9821,"value":38267.4937,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":7754.0531,"source":{"system":"sec-edgar","filing":"0001209191-17-023543","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919117023543/doc4.xml","form_type":"4"}},{"id":4425849,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Stock Appreciation Right","published_at":"2017-02-24T23:50:34.000Z","date":"2017-02-22","kind":"grant","acquired":true,"shares":1400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"On February 5, 2014, the reporting person was granted 7,000 stock appreciation rights. The stock appreciation rights are eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2016, 80% of the stock appreciation rights subject to such criteria vested, resulting in the vesting of 1,400 stock appreciation rights."}],"balance_after":1400,"derivative":{"exercise_price":47.97,"exercise_date":"2017-02-22","expiration_date":"2024-02-05","underlying":"Common Stock","underlying_shares":1400},"source":{"system":"sec-edgar","filing":"0001209191-17-014520","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919117014520/doc4.xml","form_type":"4"}},{"id":4425848,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Stock Appreciation Right","published_at":"2017-02-24T23:50:34.000Z","date":"2017-02-22","kind":"grant","acquired":true,"shares":1700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On February 6, 2013, the reporting person was granted 8,500 stock appreciation rights. The stock appreciation rights are eligible to vest in equal increments of up to 25% at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2016, 80% of the stock appreciation rights subject to such criteria vested, resulting in the vesting of 1,700 stock appreciation rights."}],"balance_after":1700,"derivative":{"exercise_price":37.18,"exercise_date":"2017-02-22","expiration_date":"2023-02-06","underlying":"Common Stock","underlying_shares":1700},"source":{"system":"sec-edgar","filing":"0001209191-17-014520","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919117014520/doc4.xml","form_type":"4"}},{"id":4425847,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Common Stock","published_at":"2017-02-24T23:50:34.000Z","date":"2017-02-22","kind":"tax_withholding","acquired":false,"shares":358,"price":85.91,"value":30755.78,"ownership":{"direct":true},"balance_after":1357.0531,"source":{"system":"sec-edgar","filing":"0001209191-17-014520","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919117014520/doc4.xml","form_type":"4"}},{"id":4425846,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Common Stock","published_at":"2017-02-24T23:50:34.000Z","date":"2017-02-22","kind":"grant","acquired":true,"shares":400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On February 5, 2014, the reporting person was granted 2,000 restricted stock units. The restricted stock units are eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2016, 80% of the restricted stock units subject to such criteria vested, resulting in the vesting of 400 restricted stock units."}],"balance_after":1715.0531,"source":{"system":"sec-edgar","filing":"0001209191-17-014520","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919117014520/doc4.xml","form_type":"4"}},{"id":4425845,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Common Stock","published_at":"2017-02-24T23:50:34.000Z","date":"2017-02-22","kind":"grant","acquired":true,"shares":451,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 6, 2013, the reporting person was granted 2,250 restricted stock units. The restricted stock units are eligible to vest in equal increments of up to 25% at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2016, 80% of the restricted stock units subject to such criteria vested, resulting in the vesting of 451 restricted stock units."}],"balance_after":1315.0531,"source":{"system":"sec-edgar","filing":"0001209191-17-014520","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919117014520/doc4.xml","form_type":"4"}},{"id":4465078,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Restricted Stock Units","published_at":"2017-02-08T00:14:23.000Z","date":"2017-02-06","kind":"exercise","acquired":false,"shares":564,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 6, 2013, the reporting person was granted 2,250 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"expiration_date":"2023-02-06","underlying":"Common Stock","underlying_shares":564},"source":{"system":"sec-edgar","filing":"0001209191-17-008459","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919117008459/doc4.xml","form_type":"4"}},{"id":4465077,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Restricted Stock Units","published_at":"2017-02-08T00:14:23.000Z","date":"2017-02-05","kind":"exercise","acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 5, 2014, the reporting person was granted 2,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":500,"derivative":{"expiration_date":"2024-02-05","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001209191-17-008459","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919117008459/doc4.xml","form_type":"4"}},{"id":4465076,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Common Stock","published_at":"2017-02-08T00:14:23.000Z","date":"2017-02-06","kind":"tax_withholding","acquired":false,"shares":237,"price":82.67,"value":19592.79,"ownership":{"direct":true},"balance_after":10864.0531,"source":{"system":"sec-edgar","filing":"0001209191-17-008459","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919117008459/doc4.xml","form_type":"4"}},{"id":4465075,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Common Stock","published_at":"2017-02-08T00:14:23.000Z","date":"2017-02-06","kind":"exercise","acquired":true,"shares":564,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":11101.0531,"source":{"system":"sec-edgar","filing":"0001209191-17-008459","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919117008459/doc4.xml","form_type":"4"}},{"id":4465074,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Common Stock","published_at":"2017-02-08T00:14:23.000Z","date":"2017-02-05","kind":"tax_withholding","acquired":false,"shares":210,"price":83.8,"value":17598.0,"ownership":{"direct":true},"balance_after":10537.0531,"source":{"system":"sec-edgar","filing":"0001209191-17-008459","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919117008459/doc4.xml","form_type":"4"}},{"id":4465073,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Common Stock","published_at":"2017-02-08T00:14:23.000Z","date":"2017-02-05","kind":"exercise","acquired":true,"shares":500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":10747.0531,"source":{"system":"sec-edgar","filing":"0001209191-17-008459","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919117008459/doc4.xml","form_type":"4"}},{"id":4469945,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Stock Appreciation Right","published_at":"2017-02-04T00:26:22.000Z","date":"2017-02-01","kind":"grant","acquired":true,"shares":14680,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock appreciation rights vest in four equal annual installments beginning on February 1, 2018."}],"balance_after":14680,"derivative":{"exercise_price":81.96,"exercise_date":"2018-02-01","expiration_date":"2027-02-01","underlying":"Common Stock","underlying_shares":14680},"source":{"system":"sec-edgar","filing":"0001209191-17-007894","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919117007894/doc4.xml","form_type":"4"}},{"id":4469944,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Common Stock","published_at":"2017-02-04T00:26:22.000Z","date":"2017-02-01","kind":"sale","acquired":false,"shares":15901,"price":82,"value":1303882.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of shares reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":10247.0531,"source":{"system":"sec-edgar","filing":"0001209191-17-007894","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919117007894/doc4.xml","form_type":"4"}},{"id":4487218,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Stock Appreciation Right","published_at":"2017-01-20T00:55:52.000Z","date":"2017-01-17","kind":"exercise","acquired":false,"shares":2750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The stock appreciation rights vest in four equal annual installments beginning on February 4, 2016."}],"balance_after":8250,"derivative":{"exercise_price":68.96,"expiration_date":"2025-02-04","underlying":"Common Stock","underlying_shares":2750},"source":{"system":"sec-edgar","filing":"0001209191-17-004684","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919117004684/doc4.xml","form_type":"4"}},{"id":4487217,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Stock Appreciation Right","published_at":"2017-01-20T00:55:52.000Z","date":"2017-01-17","kind":"exercise","acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The stock appreciation rights vest in four equal annual installments beginning on February 5, 2015."}],"balance_after":3500,"derivative":{"exercise_price":47.97,"expiration_date":"2024-02-05","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001209191-17-004684","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919117004684/doc4.xml","form_type":"4"}},{"id":4487216,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Stock Appreciation Right","published_at":"2017-01-20T00:55:52.000Z","date":"2017-01-17","kind":"exercise","acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On February 5, 2014, the reporting person was granted 7,000 stock appreciation rights. The stock appreciation rights are eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. EBITDA performance criteria for 2014 and 2015 was met, resulting in the vesting of 3,500  stock appreciation rights."}],"balance_after":0,"derivative":{"exercise_price":47.97,"expiration_date":"2024-02-05","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001209191-17-004684","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919117004684/doc4.xml","form_type":"4"}},{"id":4487215,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Stock Appreciation Right","published_at":"2017-01-20T00:55:52.000Z","date":"2017-01-17","kind":"exercise","acquired":false,"shares":6375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock appreciation rights vest in four equal annual installments beginning on February 6, 2014."}],"balance_after":2125,"derivative":{"exercise_price":37.18,"expiration_date":"2023-02-06","underlying":"Common Stock","underlying_shares":6375},"source":{"system":"sec-edgar","filing":"0001209191-17-004684","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919117004684/doc4.xml","form_type":"4"}},{"id":4487214,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Stock Appreciation Right","published_at":"2017-01-20T00:55:52.000Z","date":"2017-01-17","kind":"exercise","acquired":false,"shares":6375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On February 6, 2013, the reporting person was granted 8,500 stock appreciation rights. The stock appreciation rights are eligible to vest in equal increments of up to 25% at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. EBITDA performance criteria for 2013, 2014 and 2015 was met, resulting in the vesting of 6,375 stock appreciation rights."}],"balance_after":0,"derivative":{"exercise_price":37.18,"expiration_date":"2023-02-06","underlying":"Common Stock","underlying_shares":6375},"source":{"system":"sec-edgar","filing":"0001209191-17-004684","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919117004684/doc4.xml","form_type":"4"}},{"id":4487213,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Stock Appreciation Right","published_at":"2017-01-20T00:55:52.000Z","date":"2017-01-17","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock appreciation right vested in four equal annual installments beginning on February 8, 2013."}],"balance_after":0,"derivative":{"exercise_price":22.95,"expiration_date":"2022-02-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-17-004684","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919117004684/doc4.xml","form_type":"4"}},{"id":4487212,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Stock Appreciation Right","published_at":"2017-01-20T00:55:52.000Z","date":"2017-01-17","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock appreciation rights vested at the end of fiscal years 2012, 2013, 2014 and 2015 based upon the achievement of certain annual EBITDA performance targets."}],"balance_after":0,"derivative":{"exercise_price":22.95,"expiration_date":"2022-02-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-17-004684","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919117004684/doc4.xml","form_type":"4"}},{"id":4487211,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Common Stock","published_at":"2017-01-20T00:55:52.000Z","date":"2017-01-17","kind":"tax_withholding","acquired":false,"shares":26599,"price":80.93,"value":2152657.07,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 568.0531 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan."}],"balance_after":26148.0531,"source":{"system":"sec-edgar","filing":"0001209191-17-004684","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919117004684/doc4.xml","form_type":"4"}},{"id":4487210,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Common Stock","published_at":"2017-01-20T00:55:52.000Z","date":"2017-01-17","kind":"exercise","acquired":true,"shares":2750,"price":68.96,"value":189640.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 568.0531 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan."}],"balance_after":52747.0531,"source":{"system":"sec-edgar","filing":"0001209191-17-004684","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919117004684/doc4.xml","form_type":"4"}},{"id":4487209,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Common Stock","published_at":"2017-01-20T00:55:52.000Z","date":"2017-01-17","kind":"exercise","acquired":true,"shares":7000,"price":47.97,"value":335790.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 568.0531 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan."}],"balance_after":49997.0531,"source":{"system":"sec-edgar","filing":"0001209191-17-004684","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919117004684/doc4.xml","form_type":"4"}},{"id":4487208,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Common Stock","published_at":"2017-01-20T00:55:52.000Z","date":"2017-01-17","kind":"exercise","acquired":true,"shares":12750,"price":37.18,"value":474045.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 568.0531 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan."}],"balance_after":42997.0531,"source":{"system":"sec-edgar","filing":"0001209191-17-004684","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919117004684/doc4.xml","form_type":"4"}},{"id":4487207,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":169015,"kind":"person","name":"Chari Ravi S.","position":1,"cik":"0001632795","reported_name":"Chari Ravi S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-Clinical Excellence"}}],"security":"Common Stock","published_at":"2017-01-20T00:55:52.000Z","date":"2017-01-17","kind":"exercise","acquired":true,"shares":20000,"price":22.95,"value":459000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 568.0531 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan."}],"balance_after":30247.0531,"source":{"system":"sec-edgar","filing":"0001209191-17-004684","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000120919117004684/doc4.xml","form_type":"4"}}]}